The Emerging Role of Molecular Testing in Ovarian Cancer
Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.
This CME/CEU accredited supplement is jointly provided by:
Faculty
Courtney B. Cortez, NP, Indiana University Simon Cancer Center—IU Health
Cynthia L. Hunter, MS, LCGC, Indiana University Health
Patrick J. Kiel, PharmD, BCPS, BCOP, Indiana University School of Medicine, Indiana University Simon Cancer Center—IU Health
Jeanne M. Schilder, MD, Indiana University School of Medicine, Indiana University Simon Cancer Center—IU Health
This supplement is supported by an educational grant from AstraZeneca.
Editorial
The Rise of Genetic Testing in Managing Patients With Ovarian Cancer
Patrick J. Kiel, PharmD, BCPS, BCOP
Review Article
The Emerging Role of Molecular Testing in Ovarian Cancer
Patrick J. Kiel,(1) PharmD, BCPS, BCOP, Courtney B. Cortez,(2) NP, Cynthia L. Hunter,(3) MS, LCGC, and Jeanne M. Schilder,(1) MD